Researchers at the Toronto Western Hospital (TWH) Liver Clinic have found that a simple drug regimen delivered over 12 weeks achieved sustained eradication of several genotypes of the hepatitis C virus (HCV) in 99 per cent of the trial’s patients.
The study, released today in the New England Journal of Medicine, showed that receiving a once daily drug combination of sofosbuvir-velpatasvir for a 12 week period was effective in both treatment-naïve and previously treated patients with HCV genotype 1, 2, 4, 5, or 6, including those with compensated cirrhosis (where scarring of the liver has occurred but patients have yet to experience symptoms as a result of it).
“This drug regimen changes the standard of care in treating patients with HCV – we can now cure almost everyone with a very simple treatment,” said Dr. Jordan Feld, Hepatologist, Francis Family Liver Clinic, TWH and the first author of the study. “It’s incredibly gratifying to be part of research where we not only cure a disease but can also think about eliminating HCV in Canada.”
Current approved treatments for chronic HCV are not equally effective in combating the virus’ different genotypes. Testing to determine the genotype and subtype of the virus is required before treatment could be initiated. But the combination of sofosbuvir-velpatasvir has been shown to be applicable to all strains of HCV, effectively eliminating the need to test for the viral genotype – an obstacle that often delayed treatment.
The regimen was tested in an international, randomized, double-blind placebo-controlled phase three trial conducted at 81 sites in eight different countries. After 12 weeks, 99 per cent of the 624 patients who had been treated with a daily tablet of sofosbuvir-velpatasvir experienced a sustained virologic response – the medical term for eradication or cure of HCV – meaning that patients remained free of the virus three months after completing treatment. None of the 116 patients receiving a placebo experienced the same result.
“This is truly a one size fits all treatment that is very easy to administer and extremely well tolerated,” said Dr. Feld. “Our challenge now is getting treatment to those who need it. Over half of people living with hepatitis C remain undiagnosed. Fortunately this regimen, along with other advances in therapy, will allow us to move treatment out of specialty clinics so that we can deliver care and ideally cure all infected Canadians.”
Chronic HCV is known as a “silent” killer because symptoms often don’t appear until the liver is severely damaged. Left undiagnosed, HCV can lead to cirrhosis which can progress to liver failure or liver cancer. HCV is primarily spread by blood-to-blood contact and is associated with intravenous drug use, contact with poorly sterilized medical equipment and blood transfusions before 1992.
Approximately 170 million people are infected with chronic HCV worldwide with an estimated 252,000 in Canada. HCV causes the greatest burden of disease, measured in years of life lost, than any infectious disease in Canada.?
Read more: SIMPLE DRUG REGIMEN CURES HEPATITIS C VIRUS IN PATIENTS AFTER 12 WEEKS
The Latest on: Hepatitis C
[google_news title=”” keyword=”Hepatitis C” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Hepatitis C
- JAMA: Early Treatment with Antivirals Effective in Children with Hepatitis Con April 28, 2024 at 7:00 am
A recent study published in the Journal of American Medical Association unveiled a promising findings regarding the efficacy and cost-effectiveness of early treatment for children with ...
- Tests And Crackdowns On Hepatitis Outbreaks Triggered By Outbreakson April 28, 2024 at 3:29 am
There has been an alarming increase in the number of hepatitis cases in Rawalpindi’s Fauji Colony area. To protect residents from the growing health threat, extensive awareness and testing initiatives ...
- U.S. Lags Behind Other Countries in Hepatitis-C Treatmenton April 28, 2024 at 3:00 am
A Biden initiative languishes without Congressional approval. By Ted Alcorn In the 10 years since the drugmaker Gilead debuted a revolutionary treatment for hepatitis C, a wave of new therapies have ...
- Hepatitis outbreak prompts crackdown, testing driveon April 28, 2024 at 12:44 am
This crackdown is part of a broader effort to enforce cleanliness protocols and mitigate the spread of hepatitis within the community. The prevalence of hepatitis in Fauji Colony has been alarming, ...
- Hepatitis C diagnosis 'like a death sentence'on April 27, 2024 at 12:46 am
A woman who contracted hepatitis C after being given contaminated blood during a transfusion more than 50 years ago says she feels like her life "has been stolen". Hazel Busby, 73, says the ordeal ...
- Canada Will Likely Miss WHO's Hepatitis C Elimination Targeton April 25, 2024 at 3:35 am
Canada is unlikely to meet the World Health Organization's (WHO's) target of eliminating the hepatitis C virus ( HCV) by 2030, research suggested. The elimination targets for HCV include an 80% ...
- Hepatitis Kills 3500 People Each Day, Says WHOon April 24, 2024 at 7:28 pm
Although annual incidence decreased from 2.5 million in 2019 to 2.2 million in 2022, the WHO considers it to be high.
- Global Hepatitis C Virus (HCV) Testing Industryon April 22, 2024 at 12:13 pm
The Global Hepatitis C Virus (HCV) Testing Industry is on a promising growth trajectory, fueled by increasing awareness and improved diagnostic tools. According to industry estimates, the market ...
- Canada's Hepatitis C Elimination Target Likely Out of Reachon April 17, 2024 at 11:36 am
Sole focus on screening and treatment may hinder experts from meeting the WHO's 2030 goal to eliminate hepatitis C virus (HCV).
- Viral hepatitis is a silent killer. It can’t be eliminated if it isn’t trackedon April 17, 2024 at 1:30 am
Before Covid emerged, viral hepatitis killed more people in the United States than all 60 other reportable infectious diseases combined.
via Bing News